Consensus guidelines for the subsequent management of neutropenic fever after empiric therapy

In the context of significant advances in the literature, this chapter of the 2024 Australasian Consensus Guidelines for the Management of Neutropenic Fever in Patients with Cancer addresses the management of patients beyond the first 72 h, focusing on high-risk patients. A writing group - including adult and paediatric representatives across infectious diseases, microbiology, haematology, transplant and oncology across Australia and New Zealand, as well as across craft groups, including medicine, nursing and pharmacy - was developed to produce and address key management questions, overseen by a steering committee that included consumer representation. This chapter follows on from the Initial Empiric Management chapter and it complements the Ambulatory Care chapter, which is dedicated to low-risk patients. Using an extensive review of the literature, these guidelines provide consensus recommendations with evidence grading on topics including investigation of persistent and recurrent fever, common causes of non-infection-related fever and antibiotic rationalisation options, such as cessation, de-escalation and targeted therapy.

Authors

Institutions

Publication Details

Journal
Internal Medicine Journal
Published
2025-12-01
DOI
https://doi.org/10.1111/imj.70249
Citations
5
Primary Topic
Neutropenia and Cancer Infections
Type
article
Field-Weighted Citation Impact
5.23
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Consensus guidelines for the subsequent management of neutropenic fever after empiric therapy

Amy C. Legg, Ashish Bajel, Jason A. Trubiano, Olivia Bupha‐Intr et al.
5 citations
Internal Medicine Journal
Neutropenia and Cancer Infections
5.23
article

Consensus guidelines for the subsequent management of neutropenic fever after empiric therapy

Amy C. Legg, Ashish Bajel, Jason A. Trubiano, Olivia Bupha‐Intr, Paul Kinsella, Brendan McMullan, Karin Thursky, Jay Roberts, Nicholas Laundy, Joe Sasadeusz, Kylie Alcorn, Natalie Yap, Abby P. Douglas, Rachel Conyers, Louise Cooley
article en
5 citations

Abstract

In the context of significant advances in the literature, this chapter of the 2024 Australasian Consensus Guidelines for the Management of Neutropenic Fever in Patients with Cancer addresses the management of patients beyond the first 72 h, focusing on high-risk patients. A writing group - including adult and paediatric representatives across infectious diseases, microbiology, haematology, transplant and oncology across Australia and New Zealand, as well as across craft groups, including medicine, nursing and pharmacy - was developed to produce and address key management questions, overseen by a steering committee that included consumer representation. This chapter follows on from the Initial Empiric Management chapter and it complements the Ambulatory Care chapter, which is dedicated to low-risk patients. Using an extensive review of the literature, these guidelines provide consensus recommendations with evidence grading on topics including investigation of persistent and recurrent fever, common causes of non-infection-related fever and antibiotic rationalisation options, such as cessation, de-escalation and targeted therapy.

Internal Medicine JournalVol. 55(S7)
Griffith University (AU), University of Tasmania (AU), The Royal Melbourne Hospital (AU), Royal Children's Hospital (AU), Royal Women's Hospital (AU), The University of Queensland (AU), The University of Melbourne (AU), Université de Montpellier (FR), Royal Brisbane and Women's Hospital (AU), Gold Coast Hospital (AU), Peter MacCallum Cancer Centre (AU), Wellington Hospital (NZ), Royal Hobart Hospital (AU), Charles Darwin University (AU), UNSW Sydney (AU), Menzies School of Health Research (AU), Metro South Health (AU), Centre Hospitalier Universitaire de Nîmes (FR), Peter Doherty Institute (AU), Sydney Children's Hospital (AU), Murdoch Children's Research Institute (AU), Gold Coast Health (AU), Austin Health (AU)
Quality Education
Openalex Percentile: Top 4%
Neutropenia and Cancer Infections
5.23
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.